US2681582019 - Common Stock
DYNAVAX TECHNOLOGIES CORP
NASDAQ:DVAX (4/26/2024, 12:49:26 PM)
11.215
+0.04 (+0.4%)
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. The company is headquartered in Emeryville, California and currently employs 351 full-time employees. The company went IPO on 2004-02-19. The firm's products include HEPLISAV-B vaccine and CpG 1018. Its HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. The company also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. The firm is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. The company is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, which are focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza, and universal influenza.
DYNAVAX TECHNOLOGIES CORP
2100 Powell Street, Suite 720
Emeryville CALIFORNIA 94608
P: 15108485100
CEO: Ryan Spencer
Employees: 351
Website: https://www.dynavax.com/
/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative...
/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...
DVAX earnings call for the period ending December 31, 2023.
Dynavax reported better-than-expected Q4 earnings with a beat in EPS and revenue.
Here you can normally see the latest stock twits on DVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: